Product Information
NYLIA 1-35 28 TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.2116 per EA under NDC 65862089888. Its NADAC has been published 231 times since Mar 23, 2022.
FDA first approved this application on Oct 21, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Manufacturer
Aurobindo Pharma LimitedNDC
65862089888
Classification
Generic
Dosage Form
KIT
Effective Date
8/19/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA207056FDA Approved
10/21/2016
TE Code
AB
On Market Since
10/21/2016
Price Statistics
The NADAC for NYLIA 1-35 28 TABLET has been published 231 times since Mar 23, 2022, and over the history we have for it it has declined 38.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2116 per EA |
|---|---|
| All-time high | $0.3717 (Jul 13, 2022) |
| All-time low | $0.1935 (May 22, 2024) |
| 52-week high | $0.2291 |
| 52-week low | $0.1981 |
| Median price | $0.2694 |
| Average price | $0.2653 |
| Largest weekly change | +39.2% (Jun 19, 2024) |
| Weeks tracked | 231 |
| Tracking since | Mar 23, 2022 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of NYLIA 1-35 28 TABLET?
The current National Average Drug Acquisition Cost (NADAC) for NYLIA 1-35 28 TABLET, manufactured by Aurobindo Pharma Limited, is $0.2116 per EA (NDC 65862089888), effective Aug 19, 2026.
How has the price of NYLIA 1-35 28 TABLET changed over time?
Over the history we have for it, the NADAC for NYLIA 1-35 28 TABLET has declined 38.2%. It has been tracked across 231 weekly CMS publications since Mar 23, 2022.
What are the highest and lowest recorded NADAC prices for NYLIA 1-35 28 TABLET?
Since Mar 23, 2022, the NADAC for NYLIA 1-35 28 TABLET has ranged from a low of $0.1935 (May 22, 2024) to a high of $0.3717 (Jul 13, 2022), with a median of $0.2694 per EA.
Are there cheaper alternatives to NYLIA 1-35 28 TABLET?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as NYLIA 1-35 28 TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures NYLIA 1-35 28 TABLET?
NYLIA 1-35 28 TABLET (NDC 65862089888) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.